Combination of Regional Anesthetic Blocks for Femoropopliteal Bypass Surgery
To the Editor:
We have read with great interest the article by Basagan-Mogol et al 1 entitled "Combination of a Psoas Compartment, Sciatic Nerve, and T12-L1 Paravertebral Blocks for Femoropopliteal Bypass Surgery in a High-Risk Patient." It is known that general anesthesia increases postoperative complications, and central neuraxial blocks may cause serious sympathetic block and hemodynamic side effects in high-risk patients. For these reasons, peripheral regional anesthesia is generally preferred in high-risk patients.
Basagan-Mogol et al 1 used an anesthetic solution consisting of 0.33% bupivacaine with 1/200,000 epinephrine. Kocum et al 2 compared the effectiveness of ropivacaine 0.25% and bupivacaine 0.25% for surgical anesthesia and postoperative analgesia during lumbar plexus and sciatic nerve block for high-risk patients with the same volume as the psoas block (30 mL) and the sciatic nerve block (20 mL). Bupivacaine is usually used at the minimum concentration (0.25%) required for surgical anesthesia to reduce the risk as much as possible. 3, 4 It has been previously reported that 0.25% bupivacaine can provide sufficient surgical anesthesia with combined lumbar plexus and sciatic nerve blocks. 4, 5 We use this combination of regional techniques and the same concentration (0.25% bupivacaine) and also the same volumes for our high-risk patients undergoing femoropopliteal bypass surgery. In our experience, this technique achieves good patient and surgeon satisfication during and after the surgical period.
We believe that bupivacaine 0.25% is a sufficient concentration and provides adequate analgesia and safe anesthesia for high-risk patients undergoing femoropopliteal bypass surgery. 
